These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11366241)

  • 1. Compulsory licensing for bridging the gap - treatment access in developing countries: interview with James Love, Consumer Project on Technology. Interview by John S. James.
    Love J
    AIDS Treat News; 1999 Mar; (No 314):1-7. PubMed ID: 11366241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health GAP coalition--new group for international treatment access.
    AIDS Treat News; 1999 Mar; (No 315):5-6. PubMed ID: 11366560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seattle trade meeting: what can be done for treatment access? Interview with James Love. Interview by John S. James.
    AIDS Treat News; 1999 Nov; (No 331):6-7. PubMed ID: 11367128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global patent police block cost-reduction efforts.
    Kasper T
    GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International AIDS treatment momentum: interview with Paul Boneberg, Global AIDS Action Network. Interview by John S. James.
    Boneberg P
    AIDS Treat News; 1999 Aug; (No 324):1, 4-7. PubMed ID: 11366573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
    Sawyer E
    AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
    Halliburton M
    Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 11. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW
    Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
    [No Abstract]   [Full Text] [Related]  

  • 12. GATT and the gap: how to save lives.
    James JS
    AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International treatment access and research, how you can help--interview with Dr. Peter Piot of UNAIDS. Joint United Nations Programme on HIV/AIDS. Interview by John S. James.
    Piot P
    AIDS Treat News; 1996 Nov; (No 258):6-7. PubMed ID: 11363998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Africa, access, and patents: moving fast.
    James JS
    AIDS Treat News; 1999 Jul; (No 322):5-8. PubMed ID: 11366567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U.S. blocks trade agreement on generic drug access in poor countries.
    James JS
    AIDS Treat News; 2002 Dec; (386):4-6. PubMed ID: 12569874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded access and patient assistance programs for other experimental drugs from their manufacturers.
    Crit Path AIDS Proj; 1997; (No 32):44-64. PubMed ID: 11364445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethics and AIDS drugs: some countries want to suspend patent and trade laws to get lower-cost medications to the poor.
    Dowell W
    Time; 1999 Jul; 152(4):49. PubMed ID: 11657653
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
    Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
    Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compulsory licenses and access to HIV/AIDS drugs.
    Zuniga JM; Wilder R
    IAPAC Mon; 2001 Dec; 7(12):328-32. PubMed ID: 11799944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.